Clinical Features, Genetic Findings, and Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Data From a Brazilian Cohort

Natália Quintella Sangiorgi Olivetti,Luciana Sacilotto,Fanny Wulkan,Gabrielle D’Arezzo Pessente,Mariana Lombardi Peres de Carvalho,Danilo Bora Moleta,Denise Tessariol Hachul,Pedro Veronese,Carina Hardy,Cristiano Pisani,Tan Chen Wu,Marcelo Luiz Campos Vieira,Lucas Arraes de França,Matheus de Souza Freitas,Carlos Eduardo Rochitte,Sávia Christina Bueno,Vitor Bastos Lovisi,José Eduardo Krieger,Maurício Scanavacca,Alexandre da Costa Pereira,Francisco da Costa Darrieux

DOI: https://doi.org/10.1161/CIRCEP.122.011391

2023-02-02

Abstract:Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disease, causes ventricular tachycardia, sudden cardiac death, and heart failure (HF). We investigated ARVC clinical features, genetic findings, natural history, and the occurrence of life-threatening arrhythmic events (LTAEs), HF death, or heart transplantation (HF-death/HTx) to identify risk factors.METHODS:The clinical course of 111 consecutive patients with definite ARVC, predictors of LTAE, HF-death/HTx, and combined events were analyzed in the entire cohort and in a subgroup of 40 patients without sustained ventricular arrhythmia before diagnosis.RESULTS:The 5-year cumulative probability of LTAE was 30%, and HF-death/HTx was 10%. Predictors of HF-death/HTx were reduced right ventricle ejection fraction (HR: 0.93;P=0.010), HF symptoms (HR: 4.37;P=0.010), epsilon wave (HR: 4.99;P=0.015), and number of leads with low QRS voltage (HR: 1.28;P=0.001). Each additional lead with low QRS voltage increased the risk of HF-death/HTx by 28%. Predictors of LTAE were prior syncope (HR: 1.81;P=0.040), number of leads with T wave inversion (HR: 1.17;P=0.039), low QRS voltage (HR: 1.12;P=0.021), younger age (HR: 0.97;P=0.006), and prior ventricular arrhythmia/ventricular fibrillation (HR: 2.45;P=0.012). Each additional lead with low QRS voltage increased the risk of LTAE by 17%. In patients without ventricular arrhythmia before clinical diagnosis of ARVC, the number of leads with low QRS voltage (HR: 1.68;P=0.023) was independently associated with HF-death/HTx.CONCLUSIONS:Our study demonstrated the characteristics of a specific cohort with a high prevalence of arrhythmic burden at presentation, male predominance, younger age and HF severe outcomes. Our main results suggest that the presence and extension of low QRS voltage can be a risk predictor for HF-death/HTx in ARVC patients, regardless of the arrhythmic risk. This study can contribute to the global ARVC risk stratification, adding new insights to the international current scientific knowledge.

cardiac & cardiovascular systems